Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-20-047908

President sold 25,000 shares at $100.00 ($2,500,000)

  • President acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Novak Rodger President 2020-08-19 Option exercise +25,000 $14.00 $350,000 673,007 D: show line 1 in the form
Novak Rodger President 2020-08-19 Sale −25,000 $100.00 $2,500,000 648,007 D: show line 2 in the form
Open-market sales · 25,000 sh · avg $100.00 · $2,500,000

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Novak Rodger President 2020-08-19 Option exercise · Stock Option (Right to Buy) −25,000 115,826 D: show line 3 in the form
Loading xslF345X03/doc4.xml…